Welcome to LookChem.com Sign In|Join Free
  • or
6-nitro-2-phenyl-1,2-dihydroquinazolin-4(3H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

13324-84-0

Post Buying Request

13324-84-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13324-84-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13324-84-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,2 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 13324-84:
(7*1)+(6*3)+(5*3)+(4*2)+(3*4)+(2*8)+(1*4)=80
80 % 10 = 0
So 13324-84-0 is a valid CAS Registry Number.

13324-84-0Relevant academic research and scientific papers

Facile and one-pot synthesis of 1,2-dihydroquinazolin-4(3H)-ones via tandem intramolecular pinner/dimroth rearrangement

Tang, Jian-Hong,Shi, Da-Xin,Zhang, Li-Jun,Zhang, Qi,Li, Jia-Rong

, p. 632 - 641 (2010)

An efficient synthetic method for the preparation of quinazolin-4-one derivatives was designed. The facile condensation of aromatic o-aminonitriles with aromatic aldehydes catalyzed by Lewis acid give 1,2-dihydroquinazolin-4(3H) -ones in moderate to good

COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES

-

Page/Page column 171, (2016/06/14)

This invention provides novel compounds of formulae (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein the substituents are as defined in the specification. The present invention also relates to the novel compounds for use as a medicine, more in particular for the prevention or treatment of amyloid-related diseases, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, disorders characterized by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such amyloid-related diseases. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.

One-pot tandem approach for the synthesis of quinazolinones from ortho-aminobenzamides, benzyl halides and benzyl alcohols

Motevalli, Kourosh,Mirzazadeh, Roghieh,Yaghoubi, Zahra

, p. 701 - 702 (2013/02/23)

A one-pot tandem procedure is described for the synthesis of quinazolinones from benzyl halides or benzyl alcohols and ortho-aminobenzamides leading to the production of quinazolinones with high yields under mild conditions in DMSO without requiring an additional oxidant. According to the current method benzyl chlorides, benzyl bromides and benzyl alcohols bearing a range of substituents are suitable substrates.

The divergent transformations of aromatic o-aminonitrile with carbonyl compound

Tang, Jianhong,Li, Jiarong,Zhang, Lijun,Ma, Shuling,Shi, Daxin,Zhang, Qi,Yang, Liupan,Wang, Xiuzhen,Liu, Xuan,Liu, Change

experimental part, p. 533 - 542 (2012/08/27)

A modified Friedlaender conversion of the cyclocondensation of aromatic o-aminonitriles with carbonyl compounds was discovered. Systematic studies reveal that both the new transformation and the classic Friedlaender annulation in the presence of ZnCl2 constitute a pair of divergent reaction, and thecontrolled PDF transformation of this divergent reaction was achieved in the present of bases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13324-84-0